S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Federal Trade Commission is investigating ExxonMobil's $60B deal to acquire a Texas oil company
Zuckerberg sells Meta, Snowflake may be the better choice
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
A trial deciding if JetBlue can buy Spirit — and further consolidate the industry — nears its end
GitLab is developing an AI-powered market reversal 
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Federal Trade Commission is investigating ExxonMobil's $60B deal to acquire a Texas oil company
Zuckerberg sells Meta, Snowflake may be the better choice
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
A trial deciding if JetBlue can buy Spirit — and further consolidate the industry — nears its end
GitLab is developing an AI-powered market reversal 
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Federal Trade Commission is investigating ExxonMobil's $60B deal to acquire a Texas oil company
Zuckerberg sells Meta, Snowflake may be the better choice
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
A trial deciding if JetBlue can buy Spirit — and further consolidate the industry — nears its end
GitLab is developing an AI-powered market reversal 
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Federal Trade Commission is investigating ExxonMobil's $60B deal to acquire a Texas oil company
Zuckerberg sells Meta, Snowflake may be the better choice
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
A trial deciding if JetBlue can buy Spirit — and further consolidate the industry — nears its end
GitLab is developing an AI-powered market reversal 

Globant Stock Price, News & Analysis (NYSE:GLOB)

$220.84
-1.81 (-0.81%)
(As of 12/5/2023 ET)
Compare
Today's Range
$216.61
$221.34
50-Day Range
$168.28
$226.76
52-Week Range
$135.40
$227.45
Volume
309,250 shs
Average Volume
429,613 shs
Market Capitalization
$9.33 billion
P/E Ratio
61.69
Dividend Yield
N/A
Price Target
$218.38

Globant MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.82 Rating Score
Upside/​Downside
1.1% Downside
$218.38 Price Target
Short Interest
Healthy
4.29% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.55
Upright™ Environmental Score
News Sentiment
0.68mentions of Globant in the last 14 days
Based on 8 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
20.26%
From $4.54 to $5.46 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.63 out of 5 stars

Computer And Technology Sector

75th out of 592 stocks

Data Processing & Preparation Industry

4th out of 49 stocks


GLOB stock logo

About Globant Stock (NYSE:GLOB)

Globant S.A. operates as a technology services company worldwide. The company offers e-commerce, new distribution capabilities, augmented revenue management, hyper connected operation, and conversational user experience services through reinvention studios; digital lending, commercial effectiveness, finance, sustainability, regulation analytic, transformation and post-merger integration, and payment and open banking services; and game and graphic engineering, UI and UX design, game as a service, DevOps, and online services, as well as high tech tools. It also provides cloud transformation advice, building cloud environment, moving workloads to the cloud, cloud support and operation, chaos engineering, and site reliability engineering services; and data strategies, insights, data platforms, MLOps, and data as a product services. In addition, the company offers agile delivery, blockchain, business and cultural hacking, conversational interface, cybersecurity, design, digital sales and marketing, enterprise applications, internet of thing, metaverse, process optimization, quality engineering, salesforce, learning, UI engineering, and sustainable business solutions. Further, it provides digital experience platforms; product strategy, management, and delivery services; and strategic architecture consulting, platforms evolution, and augmented composable solutions. Additionally, operates Augoor, MagnifAI, StarMeUp, WaaSabi, Walmeric, GeneXus, Navigate, BeHealthy, and FluentLab platforms. It offers its services to enterprises in various industries, including media and entertainment, professional, technology and telecommunications, travel and hospitality, banks, financial services and insurance, consumer, retail and manufacturing, health care, and others. The company was formerly known as IT Outsourcing S.L. and changed its name to Globant S.A. in December 2012. Globant S.A. was founded in 2003 and is based in Luxembourg.

GLOB Stock Price History

GLOB Stock News Headlines

Globant (NYSE:GLOB) Downgraded by Itau BBA Securities
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Analysts’ Top Technology Picks: Globant SA (GLOB), Teradyne (TER)
Globant S.A. (NYSE:GLOB) Q3 2023 Earnings Call Transcript
Recap: Globant Q3 Earnings
Globant: Q3 Earnings Snapshot
Globant Reports 2023 Third Quarter Financial Results
Globant Q3 2023 Earnings Preview
Globant is about to announce earnings — here's what Wall Street expects
Major League Rugby partners with Globant
The Latest Analyst Ratings for Globant
See More Headlines
Receive GLOB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Globant and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/18/2021
Today
12/05/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/15/2024

Industry, Sector and Symbol

Industry
Data processing & preparation
Sub-Industry
N/A
Fax
N/A
Employees
27,122
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$218.38
High Stock Price Target
$250.00
Low Stock Price Target
$192.00
Potential Upside/Downside
-1.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.90
Research Coverage
11 Analysts

Profitability

Net Income
$148.89 million
Pretax Margin
9.90%

Debt

Sales & Book Value

Annual Sales
$1.78 billion
Cash Flow
$6.53 per share
Book Value
$37.15 per share

Miscellaneous

Free Float
41,141,000
Market Cap
$9.33 billion
Optionable
Optionable
Beta
1.38
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Martin Migoya (Age 55)
    Co-founder, Chairman, CEO & President
  • Mr. Martín Gonzalo Umaran (Age 55)
    Co-Founder, Chief Corporate Development Officer, President for EMEA & Director
  • Mr. Guibert Andres Englebienne (Age 57)
    Co-Founder, President of Globant X, Globant Ventures & Latin America and Director
  • Mr. Nestor Augusto Nocetti
    Co-Founder & Executive VP of Corporate Affairs
  • Mr. Juan Ignacio Urthiague
    CFO & Investor Relations Officer
  • Ms. Patricia Pomies
    Chief Operating Officer
  • Ms. Yanina Maria Conti
    Chief Accounting Officer
  • Mr. Diego Tartara
    Chief Technology Officer
  • Mr. Sebastian Arriada
    Chief Information Officer
  • Mr. Patricio Pablo Rojo
    General Counsel














GLOB Stock Analysis - Frequently Asked Questions

Should I buy or sell Globant stock right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Globant in the last twelve months. There are currently 2 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" GLOB shares.
View GLOB analyst ratings
or view top-rated stocks.

What is Globant's stock price target for 2024?

11 Wall Street analysts have issued twelve-month price objectives for Globant's shares. Their GLOB share price targets range from $192.00 to $250.00. On average, they predict the company's stock price to reach $218.38 in the next twelve months. This suggests that the stock has a possible downside of 1.1%.
View analysts price targets for GLOB
or view top-rated stocks among Wall Street analysts.

How have GLOB shares performed in 2023?

Globant's stock was trading at $168.16 at the beginning of 2023. Since then, GLOB stock has increased by 31.3% and is now trading at $220.84.
View the best growth stocks for 2023 here
.

Are investors shorting Globant?

Globant saw a drop in short interest in the month of November. As of November 15th, there was short interest totaling 1,770,000 shares, a drop of 18.8% from the October 31st total of 2,180,000 shares. Based on an average trading volume of 381,400 shares, the days-to-cover ratio is currently 4.6 days. Currently, 4.3% of the company's shares are short sold.
View Globant's Short Interest
.

When is Globant's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 15th 2024.
View our GLOB earnings forecast
.

How were Globant's earnings last quarter?

Globant S.A. (NYSE:GLOB) released its quarterly earnings data on Thursday, November, 18th. The information technology services provider reported $0.98 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.93 by $0.05. The information technology services provider earned $341.83 million during the quarter, compared to analysts' expectations of $326.80 million. Globant had a trailing twelve-month return on equity of 11.34% and a net margin of 7.76%. The company's revenue was up 65.0% on a year-over-year basis. During the same quarter last year, the business posted $0.43 earnings per share.

What guidance has Globant issued on next quarter's earnings?

Globant updated its fourth quarter 2023 earnings guidance on Thursday, November, 16th. The company provided earnings per share guidance of $1.60- for the period, compared to the consensus earnings per share estimate of $1.61. The company issued revenue guidance of $579.00M-, compared to the consensus revenue estimate of $578.82 million.

What is Martin Migoya's approval rating as Globant's CEO?

1,122 employees have rated Globant Chief Executive Officer Martin Migoya on Glassdoor.com. Martin Migoya has an approval rating of 96% among the company's employees. This puts Martin Migoya in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Globant own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Globant investors own include General Electric (GE), NVIDIA (NVDA), Alibaba Group (BABA), Block (SQ), Alteryx (AYX), Baidu (BIDU), Salesforce (CRM), Invitae (NVTA), CRISPR Therapeutics (CRSP) and JD.com (JD).

Who are Globant's major shareholders?

Globant's stock is owned by many different retail and institutional investors. Top institutional investors include JPMorgan Chase & Co. (3.82%), Morgan Stanley (3.64%), Sands Capital Management LLC (3.50%), Riverbridge Partners LLC (3.26%), Perpetual Ltd (2.99%) and William Blair Investment Management LLC (2.03%).

How do I buy shares of Globant?

Shares of GLOB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:GLOB) was last updated on 12/6/2023 by MarketBeat.com Staff

My Account -